Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition.
暂无分享,去创建一个
J. Herman | S. Nass | A. Ferguson | N. Davidson | J G Herman | A T Ferguson | N E Davidson | X Yang | S J Nass | D L Phillips | K A Butash | S M Wang | X. Yang | S. Wang | K. Butash | D. Phillips | K. A. Butash | Nancy E. Davidson | Xiaowei Yang | San Ming Wang | James G. Herman
[1] J. Herman,et al. Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer. , 2000, Cancer research.
[2] Peter L. Jones,et al. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters , 2000, Nature Genetics.
[3] S. Baylin,et al. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci , 2000, Nature Genetics.
[4] B. Oostra,et al. Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene. , 1999, Human molecular genetics.
[5] E. Ballestar,et al. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation , 1999, Nature Genetics.
[6] D. Dean,et al. Chromatin remodeling and transcriptional regulation. , 1999, Journal of the National Cancer Institute.
[7] C K Osborne,et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] G. Dunnington,et al. MDR1 gene expression in primary and advanced breast cancer. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[9] T. Hashimshony,et al. DNA methylation models histone acetylation , 1998, Nature.
[10] A. Ferguson,et al. Demethylation of the progesterone receptor CpG island is not required for progesterone receptor gene expression , 1998, Oncogene.
[11] S. Weitzman,et al. Mapping of ER gene CpG island methylation-specific polymerase chain reaction. , 1998, Cancer research.
[12] Colin A. Johnson,et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.
[13] Z. Chen,et al. Epigenetic silencing of RNA polymerase I transcription: a role for DNA methylation and histone modification in nucleolar dominance. , 1997, Genes & development.
[14] J. Herman,et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[15] S. Baylin,et al. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. , 1995, Cancer research.
[16] S. Baylin,et al. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. , 1994, Cancer research.
[17] R. Weigel,et al. Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma. , 1993, Cancer research.
[18] Howard Cedar,et al. DNA methylation affects the formation of active chromatin , 1986, Cell.
[19] K. Macrae,et al. Treatment of breast cancer. , 1972, Lancet.
[20] J. Herman,et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer , 1999, Nature Genetics.
[21] J. Rowley,et al. A strategy for genome-wide gene analysis: integrated procedure for gene identification. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[22] S. Weitzman,et al. Mapping of ER gene CpG island methylation-specific polymerase chain reaction. , 1998, Cancer research.